Meryl A. Waldman, M.D.

- Senior Research Physician: Clinical Nephrology Section, Kidney Diseases Branch
- Director: Nephrology Consult and Dialysis Service
Professional Experience
- Senior Research Physician NIDDK, NIH, 2020-present
- Chief, Clinical Nephrology Consult Service, 2020-present
- Director, Dialysis, 2020-present
- Staff Clinician of the Year, NIH, 2024
- Nancy Nossal Mentorship Award, 2022
- NIAMS Director’s Group Award: COVID-19 Systemic Autoimmunity, 2022
- NIDDK Clinical Director's Award, 2020
- Associate Research Physician, NIDDK, NIH, 2018-2020
- Staff Clinician, NIDDK, NIH, 2006-present
- Clinical Instructor, Columbia University, New York Presbyterian Hospital, Glomerular Disease Institute
- Nephrology Fellowship, Hospital of the University of Pennsylvania
- Internal medicine-Pediatrics Combined Residency, Baystate Medical Center
- M.D., Tufts University School of Medicine
Current Research
The focus of my research is the natural history, pathogenesis, and treatment of immunologically mediated glomerular diseases particularly membranous nephropathy. The goal of my research is to find novel ways to suppress autoimmune responses that lead to kidney disease as well as to find more sensitive methods to monitor disease activity.
Select Publications
- Diagnostic approaches for haematopoietic cell transplantation-associated membranous nephropathy: Novel underutilized tools.
- El Jurdi N, Waldman MA, Schulz E, Mina A, Li G, Carpenter A, Theis JD, Sethi S, Caza T, Seshan SV, Pavletic SZ.
- Br J Haematol (2025 Sep) 207:1138-1142. Abstract/Full Text
- Pregnancy outcomes in C3 glomerulopathy: a retrospective review.
- Fergus LO, Waldman M, Hall MD, Vining L, Hall J, Liu T, Zhang Y, Walker PJ, Smith RJH, Nester CM.
- BMC Nephrol (2025 May 14) 26:238. Abstract/Full Text
Research in Plain Language
I study new combinations of agents that reduce the activity of the immune system to treat individuals with immune-mediated kidney disease in which kidney cells are damaged by immune responses or inflammation.